Views: 215 Author: Vera Publish Time: 2026-10-09 Origin: Site
Content Menu
● How These Manufacturers Were Selected
>> Transparency About the List
● HA Serum Manufacturing: Technical Details Buyers Should Understand
>> Ingredient Identity Matters More Than a Generic "HA" Claim
>> Evaluate the Complete Formula, Not HA Alone
>> Use Cosmetics-Relevant Compliance Standards
● Comparison Table: Capacity, MOQ, and Certification Information
● The Top 10 HA Serum Manufacturers in China
>> 1. GUANGZHOU LAIMEI CREATIVE RESEARCH INTELLIGENT BIOLOGICAL RESEARCH CO.,LTD.
>> 2. Nox Bellcow Cosmetics Co., Ltd.
>> 3. Guangdong Bawei Biotechnology Corporation
>> 4. Ausmetics Daily Chemicals (Guangzhou) Co., Ltd.
>> 5. Guangzhou Olehana Biotechnology Co., Ltd.
>> 6. Guangzhou Xiran Cosmetics Co., Ltd.
>> 7. Guangdong Desifine Biotechnology Co., Ltd.
>> 9. Guangzhou Amarrie Cosmetics Co., Ltd.
>> 10. Metro Private Label / Guangzhou Baiyanhui Cosmetics Co., Ltd.
● Buyer's Guide: How to Qualify an HA Serum Supplier
>> Step 1: Verify the Factory and Contracting Entity
>> Step 2: Send a Comparable Technical Brief
>> Step 3: Separate Laboratory Approval From Production Approval
>> Step 4: Compare Landed Cost and Real MOQ
>> Step 5: Build Logistics Requirements Into Development
● An Insider Pitfall: "2% HA Complex" May Not Mean 2% Active HA
● Conclusion: Select the Supplier That Can Reproduce What You Approve
● FAQ
>> 1. How Can I Verify Whether a Manufacturer's ISO 22716 Certificate Has Expired?
>> 2. Does an FDA Registration Number Prove That an HA Serum Is Approved for US Sale?
>> 3. Can a Supplier's Existing EU Documentation Be Reused for My Private-Label Serum?
>> 4. Who Should Own the Formula, and Can I Transfer It to Another Manufacturer?
>> 5. How Can I Confirm That Mass Production Matches My Approved Sample?
● Reference Materials and Source Notes
China offers skincare brands a broad manufacturing ecosystem, from flexible private-label suppliers to large-scale cosmetics ODM enterprises. For procurement managers sourcing hyaluronic acid serum, the opportunity extends beyond competitive pricing: suppliers can coordinate formulation development, packaging procurement, production, testing, and export documentation within one project.
The Guangdong manufacturing corridor is particularly relevant. Guangzhou, Zhongshan, and Foshan are home to several suppliers in this guide, including LAIMEI, Bawei, Nox Bellcow, and Blackbird. Their proximity makes it practical to evaluate multiple development and manufacturing partners during a single sourcing visit. [lmoemcosmetics]
Demand also remains commercially significant. McKinsey's June 2026 beauty industry report forecasts approximately 5% annual global beauty market growth through 2030, reaching $590 billion. This is a broad beauty-market projection—not a forecast specifically for HA serum—but it supports the importance of building reliable, scalable skincare supply relationships. [mckinsey]
China's export activity provides additional context. A 2025 industry publication hosted by NATRUE reports, using CCCMHPIE analysis of customs statistics, that Chinese beauty skincare exports to Malaysia increased from $18.86 million in 2020 to $66.76 million in 2024. These figures describe one destination and product category; they should not be presented as China's total cosmetics exports or HA serum exports. [natrue]
For professional buyers, the central question is therefore not "Which supplier offers the cheapest serum?" It is "Which partner can reproduce the approved product, document its quality, and support the intended market?"
This guide evaluates suppliers against six procurement dimensions:
1. Manufacturing identity: a traceable business, factory relationship, and operating address.
2. Formulation capabilities: serum development, ingredient selection, texture adjustment, and scale-up support.
3. Quality management: relevant cosmetics GMP systems, raw-material controls, testing, and batch traceability.
4. Commercial flexibility: trial orders, packaging options, customization depth, and reorder scalability.
5. Market support: export experience and destination-specific documentation.
6. Supply reliability: realistic production scheduling, packaging coordination, and change-control procedures.
ISO 22716 is a relevant starting point because it addresses cosmetics production, control, storage, and shipment. However, a certificate alone does not establish the quality of a particular HA serum formula or guarantee delivery performance. [iso]
"Top 10" describes a procurement shortlist, not an independently audited performance ranking. The companies below have different business models and are not equally suitable for every project.
LAIMEI appears first as the commissioning company and a representative option for emerging and growing brands. Its supplied specifications are identified as company-reported information. Other profiles draw on public company materials and supplier records.
Current certificate validity, HA-specific production capacity, customer-market distribution, and contractual delivery performance were not independently verified. Missing information is marked rather than replaced with estimates.
"Hyaluronic acid" is an umbrella term in commercial discussions. A finished serum may contain sodium hyaluronate, hydrolyzed hyaluronic acid, or other HA derivatives.
Different forms and molecular-weight distributions can behave differently in topical formulations. Published research discusses these distinctions, but ingredient-level findings should not automatically be converted into finished-product claims about deep penetration or clinical performance. [pmc.ncbi.nlm.nih]
A useful raw-material specification should identify:
- The exact INCI name.
- The manufacturer and material grade.
- Assay or active-content specification.
- Molecular-weight range and applicable test method.
- Microbiological acceptance limits.
- Relevant impurity specifications.
- Storage conditions and shelf life.
- Batch-specific certificate of analysis.
Ask whether a proposed percentage refers to active HA solids or the inclusion rate of a diluted supplier blend. Those are not equivalent.
A serum's commercial performance depends on the whole formula: humectants, preservatives, rheology modifiers, supporting actives, fragrance, and packaging.
The purchasing specification should therefore define measurable acceptance criteria for appearance, odor, pH, viscosity, fill quantity, microbiological quality, and stability. It should also identify the testing conditions and methods.
For a water-based HA serum, request preservation-efficacy evidence and packaging-compatibility data rather than accepting a raw-material COA as proof that the finished product is adequately controlled. FDA cosmetics GMP guidance provides a useful framework for reviewing manufacturing and quality practices. [fda]
Ordinary topical HA serum should be evaluated as a cosmetic, not against an electronics-style certification checklist.
CE and RoHS documents are not substitutes for cosmetics safety assessment, manufacturing controls, or market-entry requirements. For EU sales, the relevant framework includes Regulation (EC) No. 1223/2009, an EU Responsible Person, a product safety report, and CPNP notification. [single-market-economy.ec.europa]
Likewise, FDA facility registration does not mean that a serum or factory is FDA approved. In September 2026, FDA reiterated that it does not issue certificates verifying cosmetic facility registration or product listing. [fda]
The figures below are not directly comparable. Annual output, factory area, production lines, and mixing-batch size measure different things. None should be interpreted as confirmed available capacity for your HA serum order.
| Supplier | Reported production scale | MOQ information | Certification or quality-system information | Procurement fit |
|---|---|---|---|---|
| LAIMEI | Company-provided: 20,000 m² base; over 50 million units annually across categories | Website advertises trial orders as low as 500 units; confirm SKU eligibility | Company reports ISO 22716 and GMPC; verify documents and manufacturing site | Emerging brands seeking integrated customization |
| Nox Bellcow | Large cosmetics ODM; HA-specific available capacity not established | Project quotation required | Public materials list ISO 22716, ISO 9001, and other systems | Larger skincare programs and broader product portfolios |
| Bawei | Integrated R&D, testing, and manufacturing; HA-specific capacity not disclosed in reviewed material | Project quotation required | Reports ISO 22716, GMPC, ISO 9001, ISO 14001 | Testing-oriented ODM development |
| Ausmetics | Established contract manufacturer; comparable annual HA output not disclosed | Project quotation required | Public materials report ISO 22716 and GMPC | Export-oriented skincare and personal care |
| Olehana | Website reports a 58,000 m² industrial park | Project quotation required | Describes GMPC-standard facilities; obtain current certificates | HA serum within coordinated skincare ranges |
| Xiran | Supplier profile reports 12 automatic/semi-automatic production lines | Project quotation required | Public materials report GMPC and ISO 22716 | Multi-category OEM/ODM sourcing |
| Desifine | Website reports a 15,000 m² facility | Project quotation required | Website presents ISO 22716 and GMPC information | Custom skincare and professional-positioned ranges |
| Blackbird Skincare | Factory/export structure described publicly; comparable capacity not established | Project quotation required | Current site-specific certificate evidence required | Brand development and supply-chain coordination |
| Amarrie | HA-specific output not established in reviewed sources | Website indicates approximately 3,000–5,000 units, depending on project | Website claims ISO 22716 and GMP; verify actual producer | Export-focused private-label skincare |
| Metro Private Label | Website reports 30–1,000 kg batch capability and four assembly lines | Confirm formula and packaging minimums separately | Company profile identifies a GMPC-certified manufacturing relationship | E-commerce and growing private-label brands |
Sources: LAIMEI website and company-provided brief; supplier websites and public profiles. Certification entries represent reported claims, not a current certificate audit. [lmoemcosmetics]
LAIMEI is a relevant first consideration for brands seeking coordinated formula development, packaging, manufacturing, and launch support without immediately committing to a large inventory position.
The company-provided brief states 13 years of skincare and cosmetics R&D/manufacturing experience. An exact incorporation year was not established from the reviewed About Us page and should be confirmed through business-registration documents.
According to the supplied company information, LAIMEI operates a 20,000 m² GMP-standard production base with annual capacity exceeding 50 million units across skincare categories. It also reports exports to more than 100 countries and regions. These are company-reported figures, not independently audited HA serum capacity or destination-market statistics.
Its public website advertises trial production with MOQ as low as 500 units, formula customization, packaging support, and after-sales assistance covering formula adjustments and logistics tracking. This service model makes it worth evaluating for smaller and midsize brands balancing development depth with inventory exposure. [lmoemcosmetics]
For a private-label HA serum project, its potential value lies in combining formulation and packaging decisions within one communication process. Buyers should test that advantage through a structured brief, documented sample revisions, and a clear escalation contact—not assume communication speed from promotional statements alone.
Before contracting, clarify:
- Which legal entity and production site will manufacture the serum.
- Whether the 500-unit option applies to the chosen formula and packaging.
- Which testing services are internal, affiliated, or outsourced.
- The scope of ISO 22716 and GMPC certificates.
- The full name, issuer, and scope of the supplied "MADS" claim.
- Whether R&D personnel figures refer to direct employees or a wider partner network.
The last distinction matters because the supplied brief describes over 1,000 associated technical personnel, while the website describes a broader team exceeding 2,000. Those figures should not be combined into an assumed in-house serum R&D headcount. [lmoemcosmetics]
Founded in 2004, Nox Bellcow is based in Zhongshan, Guangdong. Its public materials describe an ODM business focused on masks, skincare, and wipes, with OEM, ODM, and private-label services for global brands. [hknbc]
Its principal sourcing advantage is its established cosmetics manufacturing platform and ability to support a broader product portfolio. Buyers developing an HA serum alongside masks or other skincare products may find this integration useful.
Primary destination-market shares were not established in the reviewed sources. Ask for relevant export experience, serum references, and current documentation for the markets you intend to enter.
A material due-diligence point is FDA's May 2018 warning letter concerning pharmaceutical CGMP violations following a 2017 inspection. This historical drug-manufacturing action does not establish that a current cosmetic HA serum is noncompliant, but buyers should request the applicable response, remediation history, and current regulatory status. [fda]
Bawei was founded in 2006. Its official materials describe a service platform covering product planning, formulation R&D, scaled manufacturing, and efficacy testing, alongside an independent third-party testing institution. [baweicosmetic]
This makes Bawei a relevant candidate for HA serum programs requiring more than a stock formula and label change. Its development structure may suit buyers planning differentiated textures, supporting actives, or a documented claims program.
The company reports ISO 9001, GMPC, ISO 22716, and ISO 14001. However, buyers should verify the specific certified site and determine which testing services are included in the quoted development package. [baweicosmetic]
Its materials support domestic brand-service capabilities and international-facing sourcing, but a verified breakdown of major export destinations was not available. Request market-specific project evidence rather than assuming equal experience across jurisdictions.
Founded in 1998, Ausmetics develops and manufactures OEM/ODM cosmetics across skincare, body care, hair care, and hygiene products. Public company materials report ISO 22716 and GMPC and describe support for documents including COA, SDS, CPSR, and dermatological test reports. [prnewswire]
Ausmetics is worth considering when an HA serum is part of a wider export-oriented personal-care range. Its broader category coverage can help brands coordinate related products through one contract-manufacturing relationship.
The company describes worldwide exports, although primary-market percentages were not established. Buyers should confirm HA-specific development capabilities, formula ownership, and which reports are prepared for the actual final formulation rather than supplied as generic examples. [ausmetics]
Olehana's website states that it was founded in 2009 and integrates cosmetics R&D, manufacturing, supporting services, and brand incubation. It also lists a moisturizing hyaluronic face serum, giving buyers a directly relevant product-development starting point. [olehana-bio]
The company reports a 58,000 m² industrial park and GMPC-standard manufacturing facilities. These figures indicate reported infrastructure, not confirmed available HA serum output. [olehana-bio]
Olehana may suit brands developing a coordinated serum, toner, moisturizer, and mask range. Its international trade-show activity and global OEM/ODM positioning indicate an export-facing business, but verified primary-market shares were not found.
Ask whether an advertised serum is available as a stock private-label base, can be customized, or requires new development. Also confirm whether catalog availability reflects current production readiness.
A public supplier profile states that Xiran was founded in 2013 and reports 12 automatic and semi-automatic production lines. Its official skincare website describes OEM/ODM services for facial, body, hair, baby, and mother-care products. [gzxiran88.en.made-in-china]
Its practical appeal is multi-category sourcing with packaging, formulation, and export-document support. The company lists serums among its manufacturing formats and advertises assistance with documents relevant to overseas sales. [xiranskincare]
The reviewed materials do not establish its largest destination markets. Buyers should request evidence specific to the US, EU, or other intended sales region.
Some website wording describes FDA licensing or certification. Treat such language cautiously: FDA cosmetic registration is not approval, and FDA does not issue registration-compliance certificates. [fda]
Desifine states that it was founded in 2000 and operates in Guangzhou's Nansha district. Its website reports a 15,000 m² facility and presents ISO 22716 and GMPC information. [desifine]
The company describes OEM/ODM services covering product planning, formula R&D, manufacturing, and efficacy testing across skincare and other personal-care categories. [desifine]
For HA serum procurement, Desifine is a candidate for brands seeking customized positioning and a wider formulation relationship rather than a single stock SKU.
Verified primary export-market shares were not established. Ask for destination-specific documentation examples, production-scale serum samples, and evidence supporting any professional or efficacy-led positioning.
Blackbird's company profile distinguishes three milestones: a factory established in 2002, a foreign-trade division in 2009, and a formal foreign-trade company in 2015. Its stated headquarters are in Foshan, Guangdong. [linkedin]
That distinction is useful because factory operating history and export-company incorporation are not the same thing.
Blackbird describes support for independent skincare brands, corporations, and e-commerce retailers, managing development, raw materials, packaging, sampling, production, quality assessment, and delivery. [linkedin]
Its potential strength is supply-chain coordination for brands without an internal manufacturing team. However, buyers should identify the actual production entity, determine whether any activities are outsourced, and obtain certificates covering the responsible manufacturing site.
Primary destination-market shares were not verified.
Amarrie's company profile states a 2011 founding year and describes natural-herbal skincare development, production, and global brand ownership. Its website offers private-label and contract-manufacturing services and a serum collection. [amarrie]
The company profile identifies Europe as an early market for its Neutriherbs brand before broader international expansion. This suggests export-facing experience, although brand distribution should not be treated as proof of identical regulatory support for every OEM customer. [linkedin]
Its website indicates that MOQ commonly falls around 3,000–5,000 units, subject to project requirements. [amarrie]
One important qualification is that a public supplier listing classifies the entity as a trading company. Buyers should therefore establish the actual producer and certificate holder before relying on manufacturing claims. [amarriecosmetics.en.made-in-china]
Metro Private Label's company profile states that it was founded in 2014 in Guangzhou and operates as the international trading division of Guangzhou Baiyanhui Cosmetics Co., Ltd., described as a GMPC-certified skincare manufacturer. [linkedin]
Its website reports two integrated factory buildings, more than 10 in-house R&D engineers, 30–1,000 kg batch capability, and four assembly production lines. These are self-reported operating details rather than independently audited annual output. [metroprivatelabel]
Metro may suit e-commerce brands and growing skincare businesses seeking ready-to-sample bases, active-ingredient customization, packaging coordination, and repeat-order documentation.
Its website explicitly describes support for US, EU, and export-market labeling requirements. Buyers should still verify the contracting entity, producing factory, and formula-specific compliance deliverables. [metroprivatelabel]
Request the Chinese business license, actual manufacturing address, production authorization, and relevant certificates.
Ensure that the names on the contract, invoice, certificate, and production records are consistent—or that the relationship between different entities is documented.
A trader or export division is not automatically unsuitable. The risk is an undisclosed manufacturing chain with unclear responsibility.
Give every shortlisted supplier the same brief:
- Target country and sales channel.
- Intended claims and customer positioning.
- HA ingredient forms and active-content expectations.
- Texture, fragrance, and appearance requirements.
- Bottle size and dispensing format.
- First-order volume and reorder forecast.
- Target cost and documentation requirements.
This makes quotations more comparable and exposes differences in development scope.
Use a staged process:
1. Evaluate initial formulation samples.
2. Record revisions and freeze the formula version.
3. Test the selected formula in the intended packaging.
4. Review pilot or production-scale samples.
5. Approve release specifications.
6. Compare retained samples and batch records during repeat orders.
Do not approve commercial shipment solely because a laboratory sample looks attractive.
Ask suppliers to separate:
- Bulk manufacturing minimum.
- Filling minimum.
- Bottle and pump minimum.
- Decoration or printing minimum.
- Carton minimum.
- Testing and development charges.
A low serum MOQ may still require purchasing several thousand customized packaging components.
Compare landed cost, not just factory price. Freight, import charges, quality inspection, compliance work, and unusable packaging inventory can change the economics.
Request leakage and transport-compatibility evidence for the final pack. Define carton specifications, shipping responsibilities, insurance, and acceptance procedures.
Agree on the delivery milestone: completion of filling, QC release, handover to the freight forwarder, or arrival at destination. These are different commitments.
The most important overlooked sourcing question is traceability—including traceability of the percentage being advertised.
Consider a hypothetical supplier blend containing 1% active sodium hyaluronate. If the finished serum includes 2% of that blend, its contribution is 0.02% active sodium hyaluronate, not 2%.
A "2% HA complex" claim is therefore not enough to compare two quotations. Require the supplier to distinguish:
- Blend inclusion percentage.
- Active HA-solids percentage.
- Individual HA ingredient identities.
- Molecular-weight specifications.
- Raw-material supplier and approved alternatives.
This example illustrates a formulation calculation, not misconduct by any company listed here.
A second risk is uncontrolled substitution during repeat orders. Two materials can carry the same INCI name yet have different approved specifications. Include written change control for HA grade, ingredient supplier, preservative system, manufacturing process, and packaging.
The 2025 industry discussion of EFfCI GMP emphasizes supplier qualification, incoming-material controls, traceability, and documented assessment of material changes—principles that are valuable when designing a finished-serum purchasing agreement. [natrue]
China offers several viable HA serum sourcing models: flexible private-label services, integrated testing-led ODM development, large cosmetics manufacturing platforms, and export-oriented project coordination.
For emerging and midsize brands, LAIMEI is a relevant starting point because its public service model combines customization with advertised small-batch trial production. Larger or more testing-intensive programs may justify parallel evaluation of Nox Bellcow, Bawei, Ausmetics, and other suppliers in this shortlist. [lmoemcosmetics]
Send LAIMEI and your other shortlisted suppliers the same technical brief. Request formula-specific samples, a packaging plan, current certificate evidence, a testing proposal, and a written quotation. Select the partner that can demonstrate how the approved product will remain consistent through scale-up and repeat orders.
Obtain the complete certificate, not a cropped logo. Check the certificate number, legal entity, factory address, scope, issue date, and expiry date.
Contact the issuing certification body through independently obtained contact details and ask whether the certificate is current, suspended, withdrawn, or limited to a different site. Also determine whether its scope covers the actual manufacturing activities required for your serum.
ISO 22716 covers cosmetics production, control, storage, and shipment; it does not independently certify an HA percentage or marketing claim. [iso]
No. FDA explicitly states that facility registration and product listing are not cosmetic approval programs.
Manufacturers and responsible persons should maintain their own submission records. A third-party document labeled "FDA certificate" is not an FDA-issued approval or proof of product quality. Facility registration generally requires biennial renewal, while product-listing information requires annual updates, subject to applicable exemptions. [fda]
Do not assume so. First establish whether the formulation, product identity, intended use, packaging, and supporting information match your final product.
EU requirements include a designated Responsible Person and a product safety report. CPNP notification is a regulatory notification, not a transferable product-quality certificate or government endorsement. Assign responsibility for the safety report, Product Information File, notification, and updates before launch. [single-market-economy.ec.europa]
Ownership depends on the contract. A stock ODM formula, a customized supplier base, and a fully commissioned formula may carry different rights.
Specify ownership, exclusivity, confidentiality, permitted substitutions, access to quantitative formulation information, and transfer rights in writing.
If future transfer matters, negotiate access to manufacturing instructions, raw-material specifications, testing methods, and relevant development data—not merely an ingredient list.
Require an approved formula version, raw-material specifications, packaging specification, and finished-product release criteria.
Review production-scale samples and batch-specific results. Retain samples from the approved pilot and commercial batches. Define what triggers rejection, investigation, rework, or replacement.
Appearance alone is insufficient: matching color and viscosity does not establish ingredient identity, microbiological quality, or formulation consistency. Cosmetics GMP guidance supports reviewing the underlying production and quality-control system rather than relying only on final visual inspection. [fda]
Government, standards, and industry evidence used in this guide:
- FDA cosmetic facility registration and product listing requirements, including FDA's September 2026 clarification that registration is not approval. [fda]
- ISO 22716:2007 scope and cosmetics GMP guidance. [iso]
- European Commission cosmetics legislation and CPNP notification guidance. [single-market-economy.ec.europa]
- McKinsey's June 2026 beauty industry outlook. [mckinsey]
- The 2025 *China Cosmetics Regulations and Development* publication hosted by NATRUE, including customs-based China–Malaysia trade analysis and ingredient GMP discussion. [natrue]
- Research reviewing different HA forms in topical applications. [pmc.ncbi.nlm.nih]
